MOLECULAR PARTNERS A

MOLN
Delayed Swiss Exchange - 11:31 2022-11-25 am EST
6.310 CHF +0.32%

Turn to zoom
Prev.6.31000000
Open6.13000000
High6.37000000
Low6.13000000
Volume29 178
Latest news
11/16
11/10
11/10
11/10
Chart MOLECULAR PARTNERS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBearish
Resistance6,397,5512,6
Spread/Res.-1,3%-16%-50%
Spread/Supp.2,8%18%11%
Support6,145,365,69
Financials
Sales 2022 186 M 196 M 196 M
Net income 2022 114 M 121 M 121 M
Net cash 2022 186 M 197 M 197 M
P/E ratio 2022 1,86x
Yield 2022 -
Capitalization 205 M 217 M 217 M
EV / Sales 2022 0,10x
EV / Sales 2023 -0,58x
Nbr of Employees 163
Free-Float 93,8%
Company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug...
Sector :
Bio Therapeutic Drugs
Calendar :
2022-11-29 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 6,31 CHF
Average target price 12,87 CHF
Spread / Average Target 104%